245 related articles for article (PubMed ID: 19429816)
1. Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity.
Zhang Y; El-Sikhry H; Chaudhary KR; Batchu SN; Shayeganpour A; Jukar TO; Bradbury JA; Graves JP; DeGraff LM; Myers P; Rouse DC; Foley J; Nyska A; Zeldin DC; Seubert JM
Am J Physiol Heart Circ Physiol; 2009 Jul; 297(1):H37-46. PubMed ID: 19429816
[TBL] [Abstract][Full Text] [Related]
2. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway.
Seubert J; Yang B; Bradbury JA; Graves J; Degraff LM; Gabel S; Gooch R; Foley J; Newman J; Mao L; Rockman HA; Hammock BD; Murphy E; Zeldin DC
Circ Res; 2004 Sep; 95(5):506-14. PubMed ID: 15256482
[TBL] [Abstract][Full Text] [Related]
3. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart.
Edin ML; Wang Z; Bradbury JA; Graves JP; Lih FB; DeGraff LM; Foley JF; Torphy R; Ronnekleiv OK; Tomer KB; Lee CR; Zeldin DC
FASEB J; 2011 Oct; 25(10):3436-47. PubMed ID: 21697548
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiological properties of cardiomyocytes isolated from CYP2J2 transgenic mice.
Ke Q; Xiao YF; Bradbury JA; Graves JP; Degraff LM; Seubert JM; Zeldin DC
Mol Pharmacol; 2007 Oct; 72(4):1063-73. PubMed ID: 17652182
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes.
Wang GW; Klein JB; Kang YJ
J Pharmacol Exp Ther; 2001 Aug; 298(2):461-8. PubMed ID: 11454906
[TBL] [Abstract][Full Text] [Related]
6. Human carbonyl reductase overexpression in the heart advances the development of doxorubicin-induced cardiotoxicity in transgenic mice.
Forrest GL; Gonzalez B; Tseng W; Li X; Mann J
Cancer Res; 2000 Sep; 60(18):5158-64. PubMed ID: 11016643
[TBL] [Abstract][Full Text] [Related]
7. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats.
Zordoky BN; Anwar-Mohamed A; Aboutabl ME; El-Kadi AO
Toxicol Appl Pharmacol; 2010 Jan; 242(1):38-46. PubMed ID: 19796650
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948
[TBL] [Abstract][Full Text] [Related]
9. Heat shock protein 20 interacting with phosphorylated Akt reduces doxorubicin-triggered oxidative stress and cardiotoxicity.
Fan GC; Zhou X; Wang X; Song G; Qian J; Nicolaou P; Chen G; Ren X; Kranias EG
Circ Res; 2008 Nov; 103(11):1270-9. PubMed ID: 18948619
[TBL] [Abstract][Full Text] [Related]
10. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells.
Katragadda D; Batchu SN; Cho WJ; Chaudhary KR; Falck JR; Seubert JM
J Mol Cell Cardiol; 2009 Jun; 46(6):867-75. PubMed ID: 19285984
[TBL] [Abstract][Full Text] [Related]
11. CYP2J2-derived epoxyeicosatrienoic acids suppress endoplasmic reticulum stress in heart failure.
Wang X; Ni L; Yang L; Duan Q; Chen C; Edin ML; Zeldin DC; Wang DW
Mol Pharmacol; 2014 Jan; 85(1):105-15. PubMed ID: 24145329
[TBL] [Abstract][Full Text] [Related]
12. Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice.
Dolinsky VW; Rogan KJ; Sung MM; Zordoky BN; Haykowsky MJ; Young ME; Jones LW; Dyck JR
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E243-53. PubMed ID: 23695218
[TBL] [Abstract][Full Text] [Related]
13. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.
Mukhopadhyay P; Rajesh M; Bátkai S; Kashiwaya Y; Haskó G; Liaudet L; Szabó C; Pacher P
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1466-83. PubMed ID: 19286953
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
[TBL] [Abstract][Full Text] [Related]
15. Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.
Zhang W; Deng J; Sunkara M; Morris AJ; Wang C; St Clair D; Vore M
J Pharmacol Exp Ther; 2015 Nov; 355(2):280-7. PubMed ID: 26354995
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.
Shizukuda Y; Matoba S; Mian OY; Nguyen T; Hwang PM
Mol Cell Biochem; 2005 May; 273(1-2):25-32. PubMed ID: 16013437
[TBL] [Abstract][Full Text] [Related]
17. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2.
Xiao YF; Ke Q; Seubert JM; Bradbury JA; Graves J; Degraff LM; Falck JR; Krausz K; Gelboin HV; Morgan JP; Zeldin DC
Mol Pharmacol; 2004 Dec; 66(6):1607-16. PubMed ID: 15361551
[TBL] [Abstract][Full Text] [Related]
19. Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction.
Berthiaume JM; Oliveira PJ; Fariss MW; Wallace KB
Cardiovasc Toxicol; 2005; 5(3):257-67. PubMed ID: 16244371
[TBL] [Abstract][Full Text] [Related]
20. Higher Epoxyeicosatrienoic Acids in Cardiomyocytes-Specific CYP2J2 Transgenic Mice Are Associated with Improved Myocardial Remodeling.
Aliwarga T; Guo X; Evangelista EA; Lemaitre RN; Sotoodehnia N; Gharib SA; Zeldin DC; Liu Q; Totah RA
Biomedicines; 2020 May; 8(6):. PubMed ID: 32486275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]